CORRECTION article
Front. Antibiot.
Sec. Antibiotics in Clinical Settings
This article is part of the Research TopicTuberculosis treatment monitoring toolsView all 4 articles
Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials
Provisionally accepted
- Baylor College of Medicine, Houston, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Keywords: Tuberculosis, Tuberculosis - epidemiology, diagnosis, Drug Therapy, prevention and control
Received: 19 Nov 2025; Accepted: 10 Dec 2025.
Copyright: © 2025 DiNardo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Andrew DiNardo
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.